Document is current
Any future updates will be listed below
-
Authors
Ishii, Keita https://orcid.org/0000-0001-7872-4226
Suzuki, Kazuhito
Gunji, Tadahiro
Fukushima, Ryoko
Ishii, Hiroto
Uryu, Hideki
Yamauchi, Hirofumi
Tsukamoto, Kurumi
Hirano, Kei
Nagao, Riku
Nakamura, Takashi
Saito, Takeshi
Nishiwaki, Kaichi
Yano, Shingo
- License Information
-
More Information
Article History
Received: 9 August 2025
Revised: 15 January 2026
Accepted: 19 January 2026
First Online: 28 January 2026
Declarations
:
: K. Suzuki received personal fees from Janssen Pharmaceutical K.K., Sanofi, Pfizer, Bristol Meyers Squibb, Ono Pharmaceutical Company, and Takeda Pharmaceutical Company, outside the submitted work. T. Gunji received personal fees from Janssen Pharmaceutical K.K., outside the submitted work. H. Uryu received personal fees from Genmab A/S, and Chugai Pharmaceutical Company, outside the submitted work. R. Nagao received personal fees from Janssen Pharmaceutical K.K. and Sanofi, outside the submitted work. K. Nishiwaki received personal fees from Pfizer, Alexion Pharmaceuticals Inc., Argenx Japan K.K., outside the submitted work. S. Yano received personal fees from Daiichi-Sankyo and AstraZeneca, and reports other financial or non-financial interests with Otsuka Pharmaceutical Company, Kyowa Kirin Company, and Fuji Pharma Company, outside the submitted work. The other authors declare that they have no conflict of interest. Dr. Kazuhito Suzuki is editor of International Journal of Hematology.
